Request A Quote
Contact us to discuss how we can help you achieve your research goals
News & Events

Novogene Enhances Multi-Platform Sequencing Capacity with DNBSEQ-T7, Offering Comprehensive Solutions for Diverse Customer Needs

29 December 2023 – Novogene has formalised a cooperation agreement with MGI, announcing the introduction of MGI’s DNBSEQ-T7 sequencing platform, marking a significant enhancement in its range of high-throughput sequencing services to meet the increasingly diverse needs of customers worldwide.

The DNBSEQ-T7 platform, known for its high throughput of up to 7Tb per day boasts distinctive advantages such as low duplication rates, low tag jumping rates, low cost, and high accuracy. The addition of this new DNBSEQ-T7 platform is set to enable Novogene expand its applications in comprehensive genome research fields, offering flexible and diverse sequencing strategies to its global clientele.

descript
descript
descript

Peng Huanhuan, Vice President and China Region General Manager of BGI Genomics, and Li Yixue, General Manager of the Product Center at Novogene, formalized the collaboration, marking a significant stride in the industry. This collaboration is set to leverage the strengths of both companies to foster the development of large-scale genomics and empower industry partners.

Novogene’s adoption of DNBSEQ-T7 aligns with its strategic focus of providing customer-centric solutions. Novogene continues to diversify its technological platforms, emphasizing scalability and cost efficiency for researchers worldwide. The company boasts an extensive portfolio of sequencing and analytical platforms, including industry-leading technologies such as Illumina NovaSeq X Plus, Illumina NovaSeq 6000, PacBio Revio, PacBio Sequel II, PromethION Beta (Oxford Nanopore), PromethION 48 (Oxford Nanopore), Chromium Controller (10X Genomics), Olink Explore HT, Bionano Saphyr Gen2, Thermo Scientific™ Q Exactive HFTM-X, SCIEX QTRAP@ 6500+, Thermo Scientific™ Orbitrap Exploris™ 480, Bruker timsTOF pro2 among others.

Novogene’s continuous investment in cutting-edge technology platforms ensures that the evolving needs of global customers are well catered for. It has independently built the Falcon automated flexible intelligent delivery system to enable automated large-scale NGS sequencing preparation with little human intervention. Furthermore, it has built a convenient and efficient Customer Service System project management system, as well as other professional bioinformatics analysis auxiliary tools and databases, to ensure efficient and high-quality delivery from pre-sale to after-sale, solidifying Novogene as a trusted partner in scientific research.

About Novogene

Novogene is a pioneer in applying cutting-edge molecular biology technology and high-performance computing to research in the fields of life science and human health. Our vision is to continue as a global leader in the delivery of genomics services and solutions. With one of the largest sequencing capacities in the world, we utilise our deep scientific knowledge, first-class customer service and unsurpassed data quality to help clients realise their research goals in the rapidly evolving world of genomics. Novogene is committed to become your trusted genomics partner.